$IBIO
iBio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
IBIO chart
What traders are saying about $IBIO
Latest postsiBio, Inc. news
- iBio at guggenheim healthcare innovation conference: pipeline advances By Investing.com
Investing.com Canada ·
- Nuritas partners with UL to develop bioscience talent
I Love Limerick ·
- IBIO Q1'27 Earnings: revenue estimate is 25.00K USD
TradingView ·
- iBio, Inc. (IBIO) Seasonal returns chart
Yahoo Finance UK ·
- iBio Inc expected to post a loss of 7 cents a share - Earnings Preview
TradingView ·
- iBio, Inc. (0JV.DE) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- iBio (IBIO) Institutional Ownership 2026
MarketBeat ·
- iBio (Nasdaq:IBIO) - Stock Analysis
Simply Wall St ·
- iBio (IBIO) Projected to Announce Earnings on Wednesday
MarketBeat ·
- iBio to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
Yahoo Finance ·
- iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
Yahoo Finance ·
iBio, Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $100,000 | $400,000 | $225,000 | $0 |
| Net income | -$32.8M | -$18.4M | -$24.9M | -$65.0M |
| Diluted EPS | $-0.32 | $-1.75 | $-6.50 | $-106.19 |
| Total assets (year end) | – | $64.4M | $21.7M | $34.0M |
| Cash and equivalents (year end) | – | $28.7M | $7.0M | $2.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About iBio, Inc.
- Ticker
- IBIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1420720
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Frequently asked questions
What exchange is iBio, Inc. listed on?
iBio, Inc. trades on the Nasdaq under the ticker symbol IBIO.
What industry is iBio, Inc. in?
iBio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is iBio, Inc. headquartered?
iBio, Inc.'s business address on file with the SEC is in New York, NY.
When does iBio, Inc.'s fiscal year end?
iBio, Inc.'s fiscal year ends on June 30.
How much revenue did iBio, Inc. report?
iBio, Inc. reported $100,000 in revenue for calendar year 2026, according to its SEC filings.